BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31955246)

  • 1. Cognitive and behavioral status in Japanese ALS patients: a multicenter study.
    Watanabe Y; Raaphorst J; Izumi Y; Yoshino H; Ito S; Adachi T; Takigawa H; Masuda M; Atsuta N; Adachi Y; Isose S; Arai K; Yokota O; Oda M; Ogino M; Ichikawa H; Hasegawa K; Kimura H; Shimizu T; Aiba I; Yabe H; Kanba M; Kusumi K; Aoki T; Hiroe Y; Watanabe H; Nishiyama K; Nomoto M; Sobue G; Beeldman E; Hanajima R; Nakashima K;
    J Neurol; 2020 May; 267(5):1321-1330. PubMed ID: 31955246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and affective features of amyotrophic lateral sclerosis patients.
    Ohta Y; Sato K; Takemoto M; Takahashi Y; Morihara R; Nakano Y; Tsunoda K; Nomura E; Hishikawa N; Yamashita T; Abe K
    J Neurol Sci; 2017 Oct; 381():119-125. PubMed ID: 28991661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.
    Huynh W; Ahmed R; Mahoney CJ; Nguyen C; Tu S; Caga J; Loh P; Lin CS; Kiernan MC
    Expert Rev Neurother; 2020 Mar; 20(3):281-293. PubMed ID: 32031423
    [No Abstract]   [Full Text] [Related]  

  • 4. Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J).
    Watanabe Y; Beeldman E; Raaphorst J; Izumi Y; Yoshino H; Masuda M; Atsuta N; Ito S; Adachi T; Adachi Y; Yokota O; Oda M; Hanashima R; Ogino M; Ichikawa H; Hasegawa K; Kimura H; Shimizu T; Aiba I; Yabe H; Kanba M; Kusumi K; Aoki T; Hiroe Y; Watanabe H; Nishiyama K; Nomoto M; Sobue G; Nakashima K;
    J Neurol Sci; 2016 Aug; 367():51-5. PubMed ID: 27423564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients.
    Watanabe Y; Ogino M; Ichikawa H; Hanajima R; Nakashima K
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):66-72. PubMed ID: 32757854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS.
    Raaphorst J; Beeldman E; Schmand B; Berkhout J; Linssen WH; van den Berg LH; Pijnenburg YA; Grupstra HF; Weikamp JG; Schelhaas HJ; Papma JM; van Swieten JC; de Visser M; de Haan RJ
    Neurology; 2012 Sep; 79(13):1377-83. PubMed ID: 22972650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients.
    Woolley S; Goetz R; Factor-Litvak P; Murphy J; Hupf J; Garofalo DC; Lomen-Hoerth C; Andrews H; Heitzman D; Bedlack R; Katz J; Barohn R; Sorenson E; Oskarsson B; Filho AF; Kasarskis E; Mozaffar T; Nations S; Swenson A; Koczon-Jaremko A; Christodoulou G; Mitsumoto H
    Behav Neurol; 2018; 2018():5969137. PubMed ID: 30515252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods.
    Simon N; Goldstein LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):1-11. PubMed ID: 30585510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia.
    Saxon JA; Thompson JC; Harris JM; Ealing J; Hamdalla H; Chaouch A; Young C; Blackburn D; Majeed T; Gall C; Richardson AMT; Langheinrich T; Jones M; Snowden JS
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Nov; 21(7-8):606-613. PubMed ID: 32811199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis.
    Merrilees J; Klapper J; Murphy J; Lomen-Hoerth C; Miller BL
    Amyotroph Lateral Scler; 2010 May; 11(3):298-302. PubMed ID: 20222805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight in ALS: awareness of behavioral change in patients with and without FTD.
    Woolley SC; Moore DH; Katz JS
    Amyotroph Lateral Scler; 2010; 11(1-2):52-6. PubMed ID: 19714539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the
    Moglia C; Calvo A; Canosa A; Manera U; Vasta R; Di Pede F; Daviddi M; Matteoni E; Brunetti M; Sbaiz L; Cabras S; Gallone S; Grassano M; Peotta L; Palumbo F; Mora G; Iazzolino B; Chio A
    Neurology; 2024 Feb; 102(4):e208082. PubMed ID: 38261982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.
    Pilotto A; Rossi F; Rinaldi F; Compostella S; Cosseddu M; Borroni B; Filosto M; Padovani A
    Neurodegener Dis; 2016; 16(5-6):411-6. PubMed ID: 27497596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Story of the ALS-FTD continuum retold: rather two distinct entities.
    Lulé DE; Aho-Özhan HEA; Vázquez C; Weiland U; Weishaupt JH; Otto M; Anderl-Straub S; Semler E; Uttner I; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):586-589. PubMed ID: 30257969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis.
    Osborne RA; Sekhon R; Johnston W; Kalra S
    J Neurol Sci; 2014 Jan; 336(1-2):191-6. PubMed ID: 24239183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of using robotic technology to quantify sensory, motor, and cognitive impairments associated with ALS.
    Simmatis L; Atallah G; Scott SH; Taylor S
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):43-52. PubMed ID: 30688092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis.
    Lillo P; Garcin B; Hornberger M; Bak TH; Hodges JR
    Arch Neurol; 2010 Jul; 67(7):826-30. PubMed ID: 20625088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting neurobehavioral changes in amyotrophic lateral sclerosis.
    Grossman AB; Woolley-Levine S; Bradley WG; Miller RG
    Amyotroph Lateral Scler; 2007 Feb; 8(1):56-61. PubMed ID: 17364437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.